leon-nanodrugs GmbH
PrivateLast Round
VC Round
Feb 12, 2026
Total Funding Raised
$20.35M
Company Overview
leon-nanodrugs GmbH is a pharmatech company that develops and markets devices for the encapsulation of genetic material and other active pharmaceutical ingredients into nanoparticles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
leon-nanodrugs GmbH Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
leon-nanodrugs GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 12, 2026 | ||||
| Series D | Aug 6, 2024 | ||||
| Series B | Apr 16, 2020 | ||||
| Series A | Jul 27, 2015 |
leon-nanodrugs GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeCare Partners | Series A |
| Eckenstein-Geigy-Stiftung | Series D, Series B |
| TVM Capital | Series D, Series B, Series A |
| CD-Venture | Series D, Series B, Series A |
| Signet Healthcare Partners | Series D, Series A |
| The Pacific Group of Companies | Series D, Series B |
| BayBG Bayerische Beteiligungsgesellschaft | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
Dr. Wolfgang Hofmann named new Chief Executive Officer.
leon-nanodrugs GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about leon-nanodrugs GmbH's valuation, stock price, and market status.